BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-07307405 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-07307405\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07500506-11283@assetmemo.bio
DTSTAMP:20261121T004058Z
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261205
SUMMARY:PF-07307405: Phase 3 readout est. (NCT07500506)
DESCRIPTION:PF-07307405\, phase 3\, Lyme Disease.\nStudy: A Study to Learn 
 About the Safety\, Tolerability\, and Immunogenicity of a Fifth Dose of 6-
 Valent OspA-Based Lyme Disease Vaccine\nEstimated primary completion: 4 De
 cember 2026. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pf-07307
 405#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 07500506
URL:https://assetmemo.bio/drug/pf-07307405#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07226882-11283@assetmemo.bio
DTSTAMP:20261121T004058Z
DTSTART;VALUE=DATE:20280127
DTEND;VALUE=DATE:20280128
SUMMARY:PF-07307405: Phase 3 readout est. (NCT07226882)
DESCRIPTION:PF-07307405\, phase 3\, Lyme Disease.\nStudy: A Study to Learn 
 About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adul
 ts\nEstimated primary completion: 27 January 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/pf-07307405#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT07226882
URL:https://assetmemo.bio/drug/pf-07307405#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
